EFPIA - NEWSLETTER

EFPIA Newsletter 20 June 2019

European Healthcare: So much we can build on, so much left to do

A blog by Stefan Oschmann, EFPIA President, Chairman of the Executive Board and CEO of Merck

Europe has made great progress in healthcare in recent years. An EU citizen born today can expect to live 30 years longer than his or her ancestors a century ago. And much suggests that this trend will persist. From immuno-oncology to gene and cell therapy, we are seeing new medicines that give hope to patients who until recently have had no treatment options.

I am convinced that there has never been a more promising time for pharmaceutical innovation. Thanks to the digital revolution and new biotechnologies, we now have tools at our disposal that we would not have dared to dream about just a few years ago.

News

19 June 2019 EU Health Coalition calls upon the European Council to increase the total Horizon Europe budget...

Ahead of the European Council Meeting (20-21 June), the EU Health Coalition calls upon Member States to adopt a Multiannual...

20 June 2019 Working together for patients

Pharmaceutical companies continue to drive transparency and underline industry investment in Europe’s healthcare

Blogs

20 June 2019 The story behind the numbers

This week EFPIA produced its annual statistics report. What is the story behind the numbers? What are we seeing as the...

14 June 2019 Rare & childhood diseases: addressing unmet need

With the right framework in place we can continue to work together to meet the needs of children and adults living with...

17 June 2019 New study on sustainability of the European off-patent biologics market

A new study by the Pugatch Consilium, commissioned by EFPIA, shows that many European countries are focusing on maximising...

17 June 2019 Harnessing Real-World Data: Are We There Yet? (Guest blog)

For the most part, today’s health data landscape is still lingering in the 20th century. It consists largely of a myriad...

Videos

EFPIA Manifesto: Building a healthier future for Europe

We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there. Read the full EFPIA Manifesto at: https://efpia.eu/manifesto/

Protect The Spark

Every new treatment or cure starts with the spark of an idea. That spark has to be nurtured and cared for through the long and complex process of developing a medicine before it can begin to transform the lives of patients.

For The Chance To...

Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.

ENABLE Call for Action - European Gram-negative Antibacterial Engine

The ENABLE consortium is working to advance the development of promising new antibiotic compounds targeting Gram-negative bacteria such as Escherichia coli. The goal of the project is to develop attractive antimicrobial candidates for extensive preclinical studies and First-in-Human clinical trials, bringing new antibiotics to treat Gram-negative infections one step closer to patients.The video introduces ENABLE, its drug discovery platform, expert network and explains how to submit an Expression of Interest (EoI).

Events

27 JUN 2019

EFPIA 2019 Annual Conference Radisson Blu Royal Hotel, Brussels, Belgium

Making connections can advance patient care and support the European economy at a time of significant change and challenge...

Learn more →

23 JUN 2019

WIN 2019 Symposium Paris, France

A symposium dedicated to Innovation and global deployment of Precision Oncology

Learn more →

EURORDIS Black Pearl Awards 2020

NOMINATIONS for the EURORDIS Black Pearl Awards 2020 20 June 2019 (EURORDIS Black Pearl Awards)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶